Insider Trading & Ownership of Abraham Ceesay

Location: Burlington, MA
Summary: The estimated net worth of Abraham Ceesay is at least $23,127,397 dollars as of 18 Dec 2025. Abraham Ceesay is the Chief Executive Officer, Director of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $20.92M. Abraham Ceesay is the President of Cerevel Therapeutics Holdings, Inc. and owns shares of Cerevel Therapeutics Holdings, Inc. stock worth about $1.23M. Abraham Ceesay is the Director of Pacira BioSciences, Inc. and owns shares of Pacira BioSciences, Inc. (PCRX) stock worth about $569.6K. Abraham Ceesay is the Director of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and owns shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) stock worth about $408.9K.
Signature: /s/ Troy Ignelzi, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Abraham Ceesay files a new Insider Trading report.

Ownership of Abraham Ceesay

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
RAPP	Rapport Therapeutics, Inc.	Chief Executive Officer, Director	$20,920,529	-$2,891,482	-12%	17 Dec 2025
CERE	Cerevel Therapeutics Holdings, Inc.	President	$1,228,358			06 Feb 2023
PCRX	Pacira BioSciences, Inc.	Director	$569,610	-$64,005	-10%	04 Sep 2025
CRL	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	Director	$408,900			02 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.